Aside from the therapeutic effect of orexin modulators on clinical manifestations of psychiatric diseases, the overall benefit of improving sleep disturbances in these patients remains indisputable, and insomnia should be treated as a problem of its own in mental health services [3]. The gene discussed is HCRT; the disease is psychiatric disorder.